Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CELC |
---|---|---|
09:32 ET | 1058 | 14.45 |
09:34 ET | 200 | 14.24 |
09:39 ET | 400 | 14.34 |
09:41 ET | 1633 | 14.505 |
09:45 ET | 100 | 14.48 |
10:01 ET | 300 | 14.44 |
10:06 ET | 600 | 14.42 |
10:12 ET | 200 | 14.37 |
10:24 ET | 300 | 14.53 |
10:30 ET | 1000 | 14.5631 |
10:33 ET | 200 | 14.43 |
10:39 ET | 100 | 14.48 |
10:46 ET | 118 | 14.435 |
10:48 ET | 430 | 14.505 |
10:51 ET | 200 | 14.505 |
10:53 ET | 200 | 14.505 |
10:57 ET | 700 | 14.51 |
11:02 ET | 100 | 14.45 |
11:06 ET | 500 | 14.44 |
11:08 ET | 100 | 14.43 |
11:09 ET | 100 | 14.46 |
11:11 ET | 105 | 14.515 |
11:13 ET | 400 | 14.53 |
11:15 ET | 308 | 14.55 |
11:26 ET | 100 | 14.54 |
11:38 ET | 100 | 14.56 |
11:51 ET | 100 | 14.545 |
11:54 ET | 388 | 14.55 |
12:07 ET | 1339 | 14.57 |
12:09 ET | 100 | 14.57 |
12:16 ET | 646 | 14.485 |
12:21 ET | 100 | 14.48 |
12:23 ET | 200 | 14.48 |
12:25 ET | 600 | 14.505 |
12:30 ET | 100 | 14.48 |
12:36 ET | 200 | 14.51 |
12:45 ET | 1400 | 14.53 |
12:54 ET | 500 | 14.52 |
01:01 ET | 100 | 14.53 |
01:06 ET | 300 | 14.55 |
01:08 ET | 100 | 14.525 |
01:10 ET | 100 | 14.525 |
01:30 ET | 400 | 14.56 |
01:32 ET | 235 | 14.575 |
01:33 ET | 100 | 14.59 |
01:37 ET | 500 | 14.575 |
01:39 ET | 100 | 14.61 |
01:46 ET | 300 | 14.585 |
01:48 ET | 100 | 14.585 |
01:57 ET | 600 | 14.61 |
02:00 ET | 100 | 14.61 |
02:06 ET | 100 | 14.6 |
02:08 ET | 1000 | 14.59 |
02:15 ET | 400 | 14.6 |
02:18 ET | 100 | 14.59 |
02:20 ET | 702 | 14.605 |
02:24 ET | 600 | 14.575 |
02:27 ET | 300 | 14.53 |
02:29 ET | 117 | 14.54 |
02:31 ET | 300 | 14.495 |
02:33 ET | 200 | 14.48 |
02:38 ET | 200 | 14.46 |
02:40 ET | 400 | 14.46 |
02:44 ET | 500 | 14.48 |
02:51 ET | 100 | 14.505 |
02:56 ET | 464 | 14.48 |
03:02 ET | 200 | 14.505 |
03:03 ET | 220 | 14.48 |
03:07 ET | 300 | 14.46 |
03:09 ET | 200 | 14.45 |
03:12 ET | 100 | 14.42 |
03:14 ET | 600 | 14.41 |
03:25 ET | 200 | 14.38 |
03:27 ET | 100 | 14.38 |
03:32 ET | 300 | 14.44 |
03:34 ET | 100 | 14.41 |
03:36 ET | 600 | 14.38 |
03:38 ET | 100 | 14.36 |
03:39 ET | 2600 | 14.37 |
03:43 ET | 356 | 14.35 |
03:45 ET | 800 | 14.311 |
03:48 ET | 1430 | 14.32 |
03:54 ET | 284 | 14.33 |
03:56 ET | 1700 | 14.4 |
03:57 ET | 1026 | 14.41 |
03:59 ET | 29112 | 14.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Celcuity Inc | 554.7M | -5.2x | --- |
Third Harmonic Bio Inc | 555.7M | -16.5x | --- |
Instil Bio Inc | 549.7M | -3.6x | --- |
Altimmune Inc | 560.0M | -4.0x | --- |
Neurogene Inc | 545.1M | -8.2x | --- |
Q32 Bio Inc | 556.6M | -2.8x | --- |
Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications. Its lead therapeutic candidate is gedatolisib, a potent, small molecule reversible inhibitor, that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic target of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its initial clinical development programs for gedatolisib are focusing on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. Its VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells to identify new groups of cancer patients.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $554.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 37.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-2.74 |
Book Value | $5.48 |
P/E Ratio | -5.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.